Laurus Labs posts sharp rise in net profit for Q1FY26
This was on a 31% rise in revenue for Q1FY26 at Rs 1,570 crore from Rs 1,195 crore in Q1FY25.
The company attributed the growth in revenue and profitability to an increase in revenue from the contract development and manufacturing organisation (CDMO) division, which clocked a 103% growth boosted by the delivery of several new chemical entity (NCE) projects and ramp-up from new manufacturing assets. Revenues of the generics division also grew by 12%, partly due to increased formulation sales in both antiretroviral and developed markets, it added.
The company said it already commenced construction of a new gene and antibody drug conjugate (ADC) facility in Hyderabad and a microbial fermentation facility in Vizag.
You Can Also Check:
Hyderabad AQI
|
Weather in Hyderabad
|
Bank Holidays in Hyderabad
|
Public Holidays in Hyderabad
Laurus Labs founder & CEO Dr Satyanarayana Chava said growth was driven by the increasing contribution from the CDMO business and continued advancement of pipeline projects, supported by generic FDF. He said the company commenced construction of various facilities across CDMO, generics, and FDF.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India.com
25 minutes ago
- India.com
Dhoni receives Rs 60000000, Abhishek Bachchan Rs 1900000 monthly from SBI due to..., Reason will amaze you!
State Bank of India (SBI) is the largest government-owned and leading bank in the country, serving over 50 crore customers, with more than 50,000 employees and over 22,500 branches. People usually visit banks to take loans or to deposit money to save or earn interest. But the country's biggest bank pays cricketer MS Dhoni Rs 6 crore and actor Abhishek Bachchan Rs 18.5 lakh every month. You might be wondering why the bank pays these large sums of money to these two personalities. Even though Mahendra Singh Dhoni no longer plays cricket, he still enjoys immense popularity. Dhoni is a brand endorsement juggernaut, having received a hefty part of his earnings from his brand endorsements. There is a long list of companies that are utilizing Dhoni's brand image, and one of them is SBI. Since 2023, Dhoni has been an ambassador for India's largest bank, State Bank of India, and has been appearing in advertisements for SBI. SBI pays a hefty amount of money for brand endorsement. For endorsing State Bank of India (SBI)'s schemes, plans, and various banking facilities through advertisements, MS Dhoni receives an annual fee of ₹6 crores. MS Dhoni is the brand image of SBI and receives this fee for that purpose. Sharing a post, SBI's official Instagram account wrote, 'We are pleased to onboard MS Dhoni as Brand Ambassador of SBI. Mr. Dhoni's association with SBI as a satisfied customer makes him a perfect embodiment of our brand's ethos. With this partnership, we aim to reinforce our commitment to serving the nation and our customers with trust, integrity and unwavering dedication. – Mr Dinesh Khara, Chairman SBI.' The post was published on October 28, 2023. SBI also pays Abhishek Bachchan Rs 18.9 lakh every month. This is the amount the Bachchan family receives as rent because Abhishek has let out the ground floor of his opulent Juhu bungalow, Ammu and Vats, to SBI. The lease is for 15 years, and according to the lease, SBI pays the Bachchan family Rs 18.9 lakh every single month as rent. In fact, according the the report published on Abhishek makes this amount without any effort. The property, located near the Bachchan family's residence 'Jalsa,' spans 3,150 square feet. Essentially, Abhishek Bachchan makes almost ₹19 lakh, just for a ground-floor flat rental. The lease agreement was registered on September 28, 2021. The lease agreement spans 15 years and includes scheduled rent hikes over time: After 5 years, the monthly rent will increase to Rs 23.6 lakh. After 10 years, it will further rise to Rs 29.5 lakh.
Economic Times
25 minutes ago
- Economic Times
Market in consolidation mode; triggers needed, says Sunil Subramaniam
Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads "Another reason for pharma's past underperformance is that FIIs were driving the selling pressure. They closely track export-oriented sectors. So the recent post-results bounce in pharma is largely driven by DIIs. FIIs still haven't firmed up their stance on India. They remain a bit cautious, especially because the delay in the BTA (Bilateral Trade Agreement) hasn't helped sentiment," says Sunil Subramaniam , Market like you said, the question is—why were they under pressure in the first place? I'd call it the Trump effect. Mr. Trump has been talking a lot about imposing heavy pharma tariffs. He hasn't actually done anything yet, but every time he makes such statements, it creates nervousness—whether he's targeting CDMO players or generics, and how he plans to go about it. That uncertainty has impacted the pharma sector, putting it under when individual companies are reporting good numbers, the market has no choice but to buy into them—because at least those companies are indicating a positive outlook. Plus, some of them may not even be impacted by tariffs, creating a window of opportunity. Also, the pharma space includes domestic-oriented businesses like hospitals and diagnostics, which are unaffected by U.S. tariff issues. So overall, pharma remains a defensive reason for pharma's past underperformance is that FIIs were driving the selling pressure. They closely track export-oriented sectors. So the recent post-results bounce in pharma is largely driven by DIIs. FIIs still haven't firmed up their stance on India. They remain a bit cautious, especially because the delay in the BTA (Bilateral Trade Agreement) hasn't helped we need to understand the market's movement over the last three months. Post-March, FIIs were actually buyers in April and May, and even in June, though to a lesser extent. Meanwhile, if you look at the end of March, mutual fund DIIs—especially domestic mutual funds—had built up cash positions to around 7.25% of their April and May, both mutual funds and FIIs were buying, which supported the market. But starting this month, mutual fund cash levels are back down to around 5%, which is close to their lower limit. That means DIIs don't have as much cash left to deploy, apart from the fresh SIP looking at last earnings season and market levels, domestic funds have largely deployed their cash. FIIs, on the other hand, had expected some action around the BTA by July 9, which then got pushed to August 1. But now, even that deadline seems unlikely to be met. The Indian trade delegation has returned from the U.S. without a deal. Sticking points remain—like agriculture—and they won't be easy to the question now is whether Trump will extend the 10% tariff pause beyond August 1 or slap a 26% tariff on India and then negotiate, like he did with Japan—imposing higher tariffs first and then signing a deal at 19%. That kind of uncertainty around the India-U.S. BTA is keeping FIIs factor is China. While China and the U.S. haven't signed a full BTA either, they seem to have reached some understanding. Meanwhile, China's markets have been beaten down so much that the one-year forward P/E is around 11—compared to India's 22. And China's economy is about 4.5 times larger than India's. Even at 4% growth, those are big numbers. So FIIs are starting to see more value in China, pulling some attention away from as for your question on the next trigger—clearly, a breakthrough on the BTA front, like an interim deal or assurance that tariffs will be capped below 20%, could bring FIIs back. On the domestic side, it's the ongoing earnings season. Results have been mixed. The IT sector, for instance, didn't post terrible earnings, but weak guidance is weighing heavily, especially in the absence of FII DIIs have already used most of their cash, their incremental buying will depend on the inflow from SIPs and earnings results. So companies with strong earnings and forward guidance will likely get DII if the early festival season gives good signs on the consumption front, that could also be a positive trigger. Until then, expect the market to remain in a sideways, consolidative phase for some time.
Indian Express
25 minutes ago
- Indian Express
CAT 2025 Notification: IIM Kozhikode to start registration from Aug 1; exam on November 30
The Indian Institute of Management (IIM) Kozhikode will organise this year's Common Admission Test (CAT). The registration for CAT 2025 will start from August 1, and the exam will be held on Sunday, November 30. The notification was released in various national newspapers; however, the IIM Kozhikode will make the official website of the CAT 2025 live soon. The link for registration is This is the same website that was used in CAT 2024. The Common Admission Test (CAT) 2025 is scheduled to be conducted in three sessions through a computer-based test (CBT) format. An official notification detailing the exam and related guidelines will likely be published shortly on the CAT website. For this year, the registration fee has been set at Rs 1,300 for candidates belonging to SC, ST, and PwD categories, while all other applicants will need to pay Rs 2,600. The application process for CAT 2025 will commence on August 1 at 10 am and conclude on September 13 by 5 pm. Admit cards will be made available to candidates starting November 5, ahead of the exam scheduled for November 30. The results are tentatively expected in the first week of January 2026. This year, the examination will be conducted across approximately 170 cities, and candidates will have the opportunity to choose up to five preferred cities while selecting their test centres. –While applying for CAT 2025, candidates are required to upload scanned copies of their Class 10 and 12 mark sheets, along with either graduation certificates or their most recent semester results if they're currently in the final year. Applicants may also include work experience certificates, where relevant. Additionally, a valid photo ID and applicable category certificates for SC, ST, or PwD candidates need to be uploaded. –A recent passport-size photograph and signature are mandatory, and final-year students must also provide a certificate issued by their respective institution. CAT 2025 serves as an entrance gateway for admission to postgraduate as well as fellow/doctoral programmes offered by the Indian Institutes of Management (IIMs) and other participating institutions. However, it is important to note that CAT scores are just one component of the overall selection process. Candidates will be required to take part in additional evaluation stages, the specifics of which will be announced later on the respective institute websites. Last year, the Indian Institute of Management (IIM) Calcutta conducted the exam, wherein 14 candidates had scored 100 percentile, of which only one was a woman. Moreover, 13 aspirants were from an engineering background, while only one was a non-engineer. Of the 2.93 lakh candidates who appeared for the exam in 2024, 1.07 lakh were female candidates, 1.86 lakh were male candidates, and 5 were transgender candidates.
